ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 166 filers reported holding ANTARES PHARMA INC in Q3 2020. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,885,000 | +20.1% | 1,191,359 | +4.5% | 0.00% | 0.0% |
| Q4 2021 | $4,069,000 | +162.5% | 1,139,703 | +167.7% | 0.00% | – |
| Q3 2021 | $1,550,000 | -3.9% | 425,798 | +15.1% | 0.00% | – |
| Q2 2021 | $1,613,000 | +47.3% | 369,980 | +38.8% | 0.00% | – |
| Q1 2021 | $1,095,000 | -65.1% | 266,508 | -66.1% | 0.00% | -100.0% |
| Q4 2020 | $3,136,000 | +21.0% | 785,958 | -18.1% | 0.00% | 0.0% |
| Q3 2020 | $2,592,000 | +13.5% | 960,031 | +15.6% | 0.00% | 0.0% |
| Q2 2020 | $2,283,000 | +66.2% | 830,309 | +42.6% | 0.00% | – |
| Q1 2020 | $1,374,000 | -73.0% | 582,467 | -46.1% | 0.00% | -100.0% |
| Q4 2019 | $5,083,000 | +338.2% | 1,081,480 | +211.9% | 0.00% | – |
| Q3 2019 | $1,160,000 | +106.4% | 346,697 | +103.2% | 0.00% | – |
| Q2 2019 | $562,000 | -45.1% | 170,585 | -49.5% | 0.00% | – |
| Q1 2019 | $1,023,000 | +180.3% | 337,685 | +151.6% | 0.00% | – |
| Q4 2018 | $365,000 | +7.0% | 134,193 | +32.3% | 0.00% | – |
| Q3 2018 | $341,000 | +23.1% | 101,453 | -5.2% | 0.00% | – |
| Q2 2018 | $277,000 | +2.2% | 107,043 | -13.3% | 0.00% | – |
| Q1 2018 | $271,000 | +5.4% | 123,511 | -4.6% | 0.00% | – |
| Q4 2017 | $257,000 | -76.3% | 129,470 | -61.3% | 0.00% | – |
| Q3 2017 | $1,084,000 | -11.3% | 334,507 | -11.9% | 0.00% | – |
| Q2 2017 | $1,222,000 | -25.4% | 379,642 | -34.2% | 0.00% | – |
| Q1 2017 | $1,638,000 | +433.6% | 576,664 | +338.0% | 0.00% | – |
| Q4 2016 | $307,000 | -40.4% | 131,655 | -57.0% | 0.00% | – |
| Q3 2016 | $515,000 | +64.5% | 306,502 | +2.9% | 0.00% | – |
| Q2 2016 | $313,000 | +1465.0% | 297,915 | +1200.5% | 0.00% | – |
| Q1 2016 | $20,000 | -86.2% | 22,908 | -80.9% | 0.00% | – |
| Q4 2015 | $145,000 | -42.7% | 120,059 | -19.2% | 0.00% | – |
| Q3 2015 | $253,000 | +72.1% | 148,535 | +110.5% | 0.00% | – |
| Q2 2015 | $147,000 | -16.0% | 70,568 | +9.2% | 0.00% | – |
| Q1 2015 | $175,000 | -31.6% | 64,595 | -35.2% | 0.00% | – |
| Q4 2014 | $256,000 | +46.3% | 99,682 | +4.2% | 0.00% | – |
| Q3 2014 | $175,000 | -28.9% | 95,654 | +3.6% | 0.00% | – |
| Q2 2014 | $246,000 | -28.7% | 92,306 | -6.3% | 0.00% | – |
| Q1 2014 | $345,000 | -41.1% | 98,542 | -24.8% | 0.00% | – |
| Q4 2013 | $586,000 | +70.3% | 130,978 | +54.4% | 0.00% | – |
| Q3 2013 | $344,000 | -80.3% | 84,827 | -79.8% | 0.00% | -100.0% |
| Q2 2013 | $1,744,000 | +1317.9% | 419,277 | +1203.2% | 0.00% | – |
| Q4 2012 | $123,000 | -26.8% | 32,172 | -16.6% | 0.00% | – |
| Q3 2012 | $168,000 | -90.0% | 38,568 | -91.6% | 0.00% | -100.0% |
| Q2 2012 | $1,675,000 | +1131.6% | 461,321 | +998.5% | 0.00% | – |
| Q1 2012 | $136,000 | – | 41,994 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,180,000 | 4.34% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,535,727 | $11,056,000 | 3.87% |
| Sargent Investment Group, LLC | 3,596,250 | $15,680,000 | 3.72% |
| Rubric Capital Management LP | 9,500,000 | $41,420,000 | 2.61% |
| PERKINS CAPITAL MANAGEMENT INC | 541,783 | $2,362,000 | 1.34% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $8,284,000 | 1.14% |
| Venator Capital Management Ltd. | 709,700 | $3,094,000 | 1.05% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $523,000 | 0.22% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $875,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,199,000 | 0.19% |